Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

09 Aug 22
Cronos Group Reports 2022 Second Quarter Results
Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022 Announced achievement of THCV equity milestone TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc.
13 Jul 22
Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 second quarter earnings conference call on Tuesday, August 9, 2022 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and
27 Jun 22
Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster Absorption
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is pleased to announce the launch of the first of what is expected to be a range of products, in partnership with Geocann, which will utilize the advanced VESIsorb ® delivery system.

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Report of unscheduled material events or corporate event


09 August 2022 at 8:30 AM EDT
Cronos Group Second Quarter 2022 Earnings Conference Call
23 June 2022 at 11:00 AM EDT
2022 Annual Meeting of Shareholders
19 May 2022 at 2:00 PM EDT
BMO 17th Annual Global Farm to Market Conference